Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome

Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García‐Hoz F, Sánchez J, Gil‐Grande L, Nuño J, Fortún J, Rodriguez‐Sagrado MA, Moreno A. Partial splenic embolization and peg‐IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long‐term outcome. Clin Transplant 2010: 24: 366–374. © 2009 John Wiley & Sons A/S. : Background: There is limited information on the long‐term outcome in liver transplant (LT) subjects undergoing partial splenic embolization (PSE) prior to full dose pegylated interferon/ribavirin (peg‐IFN/RBV). Methods: Retrospective review of eight LT subjects after PSE and antiviral therapy. Results: Baseline platelets and neutrophils were